Myeloperoxidase Isoform C now available from Lee Biosolutions

July 19, 2006; St. Louis, Missouri – Lee Biosolutions has recently begun offering the antigen, Myeloperoxidase (MPO) Isoform C for sale to the clinical research community.

MPO Isoform C is a popular enzyme among the community of protein structural researchers, including X-ray crystallographers. In order to avoid any potential confusion, these researchers prefer to specifically work with MPO isoform C, rather than a mixed population of MPO.

According to company President Burton Lee, Lee Biosolutions is in constant communication with its customers to determine trends and anticipate product needs before they happen. The company’s Research and Development staff’s goal is to stay a step ahead of researchers and have the materials they need before they need them.

“We understand the critical role our products play in the clinical research process,” Lee said. “By maintaining higher purity and quality standards, we aim to provide clients with a wider variety of reliably consistent products.”

Lee Biosolutions’ customers are clinical researchers around the world who rely on the company to provide the highest quality products to aid in the development of tomorrow’s cures.

For over 30 years, Lee Biosolutions has been providing proteins, enzymes and other materials to research facilities around the country that work to advance the healthcare industry. By providing Solutions on Demand, Lee Biosolutions has become the preferred source for materials such as renin and myeloperoxidase (MPO). The company recently launched the informational site www.MPOFacts.com as a resource for labs using the enzyme.

For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company’s newly redesigned website, www.leebio.com.